Trial Profile
A phase III study of AZ01 for the treatment of relapsing‐remitting multiple sclerosis (RRMS)
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Apr 2016
Price :
$35
*
At a glance
- Drugs Interferon beta (Primary)
- Indications Multiple sclerosis
- Focus Registrational; Therapeutic Use
- 15 Apr 2016 New trial record